Skip to main content

Advertisement

Contact Bertrand Lell

From: Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection

Contact corresponding author